Common questions about Gynoflor (FAQ)
Q: How quickly do most people notice a change after starting Gynoflor?
Studies describe the initiation of the beneficial effects of the Lactobacillus occurring within a few hours as the vaginal pH begins to lower. The initiation of the estriol effect on the vaginal lining is also noted quickly. Improvement may progress over the course of treatment, according to the official product information.
Q: Is Gynoflor meant for long-term use?
Gynoflor is typically used as a short-term course of treatment. Official information describes the use of repetitive courses in research for the prevention of recurrent issues. However, long-term effects regarding sustained prevention require further clinical investigation.
Q: Do studies support the use of Gynoflor for recurring vaginal issues?
Official studies investigate the use of repetitive courses of therapy for the prevention of recurrent bacterial vaginosis. While this research theme exists, official sources note that further long-term clinical study is needed to fully substantiate the benefit of this prolonged application.
Q: Can women who have gone through menopause still use Gynoflor?
Official product information states that this combination product has been used in both pre- and postmenopausal women. The product is indicated for the treatment of symptomatic vaginal atrophy, a condition often experienced after menopause. Regulatory data show that plasma estriol levels remained within the normal range for postmenopausal women after repeated use.
Q: Is Gynoflor a treatment for Bacterial Vaginosis (BV)?
Gynoflor is indicated for the restoration of vaginal flora following anti-infective therapy and for abnormal vaginal flora. Studies have examined its use in repetitive courses for the prevention of recurring bacterial vaginosis, which relates to a common imbalance in the vaginal flora.
Q: Can Gynoflor interact with products like vaginal washes or douches?
Regulatory guidelines include the instruction that deep vaginal irrigation, such as douching, must be avoided during treatment with Gynoflor. This restriction is in place to support the local action and effectiveness of the vaginal tablet.
Q: Is Gynoflor used to prevent future occurrences?
The product is indicated for use to help prevent recurrent vaginal infections in women. Clinical studies have specifically examined its use in repetitive courses for the long-term prevention of recurrent bacterial vaginosis.
Q: Has Gynoflor been studied in pregnant women?
Official product leaflets state that use during pregnancy and breastfeeding is generally considered. Clinical reviews of the product have noted that the combination did not raise major safety concerns, even when considered during pregnancy.
Q: Does Gynoflor help with vaginal dryness?
The product is indicated for the treatment of symptoms of vaginal atrophy due to estrogen deficiency, which includes the symptom of vaginal dryness. The estriol component's mechanism involves promoting the proliferation and maturation of the vaginal lining.
Q: Is Gynoflor considered a hormone replacement therapy (HRT)?
Gynoflor is described as an ultra-low dose estriol and probiotic combination. Unlike systemic hormone replacement therapies (HRT), the estriol component is intended to have a specific local effect on the vagina without stimulating the uterine lining.
Q: How long after finishing the treatment can I expect the benefits to last?
Research has investigated the durability of the product's benefits, specifically in relation to vaginal atrophy. Research found that maintenance therapy was utilized to support the initial benefits by applying a maintenance dose over a longer period.
Q: Are there any long-term consequences of using Gynoflor?
Due to the ultra-low dose of estriol and local application, systemic estrogen effects are described as unlikely. However, official risk management plans note that potential long-term risks associated with systemic estrogen, such as endometrial hyperplasia, require ongoing monitoring.
Q: Is the estriol component of Gynoflor absorbed into the rest of the body?
Regulatory data indicates that after a single application, the plasma concentration of estriol increases only briefly. After repeated use over a course of treatment, accumulation was not detected, with plasma levels remaining within the normal range of endogenous levels found in post-menopausal women.
Q: Is Gynoflor a form of antibiotic?
Gynoflor is classified by regulatory authorities as a 'Gynecological Anti-infective and Antiseptic.' This is a broad category that includes treatments targeting various pathogens and restoring the natural environment.
Q: Is Gynoflor available over the counter or is it prescription-only?
The dispensing status of Gynoflor can vary significantly depending on the region. Official regulatory documents indicate that in some areas it may be available without a prescription, while in others it is classified as a prescription-only drug.
Q: What is the difference between Gynoflor and other probiotic vaginal suppositories?
Official product descriptions state that Gynoflor is characterized by the combination of both estriol (a hormone) and Lactobacillus acidophilus. This combination provides both the probiotic component and a local trophic effect on the vaginal lining.
Q: Can Gynoflor be used alongside an oral antifungal medication?
Official product information states that Lactobacillus acidophilus is sensitive to various anti-infective agents, including those that may be taken systemically (orally). Simultaneous use of Gynoflor with these types of medications may reduce the effectiveness of the Lactobacillus component.
Q: Can Gynoflor be used during menstruation?
Regulatory guidelines contain a restriction against using vaginal suppositories during menstruation. The instructions suggest waiting until the menstrual period is completely over before continuing the treatment.
Q: What happens if a tablet is missed?
Official instructions address missed doses by stating the dose may be used as soon as remembered; however, if it is nearly time for the next dose, the instruction is to skip the missed one. The instructions also state that a double dose must not be used to compensate.
Q: Are there specific storage instructions for Gynoflor, like refrigeration?
Regulatory instructions specify that the product must be stored under refrigeration, typically between 2 C – 8 C. However, official information describes that storage at room temperature for short periods, such as 1 – 2 weeks, is not reported to compromise efficacy.
Q: Does Gynoflor contain any ingredients that might cause an allergic reaction?
Official contraindications warn against using Gynoflor if a patient is allergic or hypersensitive to any of the listed active ingredients or excipients. This is a standard caution found in official product documentation.
Q: How is Gynoflor different from oral probiotics?
The difference lies primarily in the route of administration and the inclusion of estriol. Gynoflor is applied locally for a more pronounced effect on the vaginal lining, aiming for local results without the systemic effects that can be associated with oral products.
Q: Do you need to use a panty liner while using Gynoflor?
Usage guidelines note that a pad or sanitary napkin may be utilized when inserting Gynoflor. This is because the excipients may not completely dissolve, and some medication residue may be noticed.
Q: Can men use Gynoflor?
The official patient information leaflet explicitly states that Gynoflor is not intended for use by men or boys. The product is consistently described for use in women.
Q: What are the inactive ingredients in Gynoflor?
Official regulatory documents list the excipients (inactive ingredients) in the tablet. These often include substances like microcrystalline cellulose, anhydrous disodium phosphate, lactose monohydrate, magnesium stearate, and sodium glycolate starch.
Q: What does 'vaginal atrophy' mean in relation to Gynoflor?
Vaginal atrophy is a condition related to estrogen deficiency that the product is indicated to treat. The purpose of the product's action in this context is to promote the proliferation and maturation of the vaginal lining.
